Received Mar 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
The two people that died from an RSV vaccine; This serious case was reported by a physician via call center representative and described the occurrence of unknown cause of death in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced unknown cause of death (Verbatim: The two people that died from an RSV vaccine) (serious criteria death and GSK medically significant). The reported cause of death was unknown. It was unknown if the reporter considered the unknown cause of death to be related to Arexvy. The company considered the unknown cause of death to be unrelated to Arexvy. Additional Information: GSK Receipt Date: 26-FEB-2025 The reporter reported that two people that have died from an RSV vaccine. The reporter would like to receive data on the circumstances surrounding their deaths. No further details provided.; Sender's Comments: Death is an unlisted event which is considered unrelated to GSK vaccine Arexvy.; Reported Cause(s) of Death: Unknown cause of death